バイオテクノロジー市場規模、シェア、成長分析：製品タイプ別、技術別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

バイオテクノロジー市場規模は2023年に2兆1,200億米ドルと評価され、2024年の2兆3,900億米ドルから2032年には6兆2,600億米ドルに成長し、予測期間（2025～2032年）のCAGRは12.79%で成長する見通しです。

バイオテクノロジー産業は高度に世界化したセクターであり、国を超えて多様な経済成長を経験しています。健康問題、特にB型肝炎や糖尿病、がんなどの慢性疾患の増加は、バイオテクノロジー・ソリューションの需要を促進すると予想されています。米国、中国、インドなどの主要国では人口が増加しており、小麦、米、サトウキビなどの農産物のニーズも高まると思われます。同時に、科学者たちは、水不足、低収量、害虫の脅威といった課題を軽減するため、スマート農業システムに焦点を当てた研究開発に積極的に取り組んでいます。政府機関や独立系企業との協力により、研究開発のための資金が増強され、バイオテクノロジーのイノベーションが促進されています。その結果、この分野の企業は、特に効果的な治療法の開発に専念している企業にとって、大きなチャンスを得る態勢が整っています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術分析

バイオテクノロジー市場規模：製品タイプ別

• 市場概要
• 機器
• 試薬
• サービス
• ソフトウェア

バイオテクノロジー市場規模：技術別

• 市場概要
• ナノバイオテクノロジー
• PCR技術
• DNAシーケンシング
• クロマトグラフィー
• 組織工学と再生
• 細胞ベースアッセイ
• 発酵
• その他

バイオテクノロジー市場規模：用途別

• 市場概要
• バイオファーマシー
• バイオ産業
• バイオサービス
• バイオインフォマティクス
• バイオ農業

バイオテクノロジー市場規模：エンドユーザー別

• 市場概要
• 製薬会社およびバイオテクノロジー企業
• 契約調査機関
• 学術研究機関
• その他

バイオテクノロジー市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Amgen Inc.（USA）
• Gilead Sciences, Inc.（USA）
• Genentech（Roche）（Switzerland）
• Biogen Inc.（USA）
• Regeneron Pharmaceuticals, Inc.（USA）
• Moderna, Inc.（USA）
• Illumina, Inc.（USA）
• Vertex Pharmaceuticals（USA）
• AbbVie Inc.（USA）
• Eli Lilly and Company（USA）
• Sanofi S.A.（France）
• Novozymes（Denmark）
• CSL Limited（Australia）
• Celgene Corporation（USA）
• Bristol-Myers Squibb Company（USA）
• Novo Nordisk（Denmark）
• AstraZeneca PLC（UK/Sweden）
• Stryker Corporation（USA）
• Merck & Co., Inc.（USA）
• Johnson & Johnson（USA）

結論と提言

Biotechnology Market size was valued at USD 2.12 trillion in 2023 and is poised to grow from USD 2.39 trillion in 2024 to USD 6.26 trillion by 2032, growing at a CAGR of 12.79% during the forecast period (2025-2032).

The biotech industry is a highly globalized sector experiencing diverse economic growth across nations. Rising health issues, particularly hepatitis B and chronic diseases like diabetes and cancer, are anticipated to drive demand for biotech solutions. The increasing populations in major countries such as the US, China, and India will also heighten the need for agricultural products, including wheat, rice, and sugarcane. Concurrently, scientists are actively engaged in R&D to mitigate challenges such as water scarcity, low crop yield, and pest threats, focusing on smart agricultural systems. Collaborative efforts with both governmental and independent entities are boosting funding for research and development, fostering innovations in biotechnology. Consequently, companies in this field are poised for significant opportunities, particularly those dedicated to developing effective treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biotechnology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biotechnology Market Segments Analysis

Global Biotechnology Market is segmented by Product Type, Technology, Application, End User and region. Based on Product Type, the market is segmented into Instruments, Reagents, Services and Software. Based on Technology, the market is segmented into Nano Biotechnology, PCR Technology,DNA sequencing, Chromatography, Tissue Engineering and Regeneration, Cell-Based Assays, Fermentation and Others. Based on Application, the market is segmented into Bio-pharmacy, Bio-industrial, Bio-services, Bioinformatics and Bio-agriculture. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biotechnology Market

The global biotechnology market is being significantly driven by the rising incidence of chronic diseases, including cancer and diabetes. As the prevalence of these health issues escalates worldwide, there is a correspondingly growing demand for effective treatments. This urgent need for innovative therapeutic solutions is propelling the expansion of the biotechnology sector on a global scale. The increasing focus on research and development in biotechnology to address these pressing health concerns is further enhancing market growth. As a result, the biotechnology industry is poised for continuous advancement and investment, driven by the imperative to combat chronic illnesses effectively.

Restraints in the Biotechnology Market

The biotechnology sector is heavily reliant on innovation, and when one company secures a patent by being the first to develop a new technology, it can create significant delays for competing firms seeking to bring similar products to market. This situation arises because competitors are unable to use patented methods without facing legal challenges, leading to potential conflicts over intellectual property rights. Such patent-related issues and overlaps can act as considerable barriers to market growth, as they restrict the ability of other companies to leverage similar technologies and diminish their competitive edge in bringing innovative solutions to consumers.

Market Trends of the Biotechnology Market

The biotechnology market is witnessing a significant trend towards synthetic biology, a rapidly growing segment poised to revolutionize various industries including pharmaceuticals, agriculture, and biofuels. This innovative approach enables companies to design and engineer biological systems for diverse applications, enhancing efficiency and sustainability. As the demand for eco-friendly solutions escalates, biotechnology firms are increasingly investing in synthetic biology to develop novel products and processes that address global challenges such as climate change and health crises. By leveraging advances in genetic engineering and computational biology, these companies are not only maximizing revenue opportunities but also positioning themselves as leaders in the future of biotechnological advancements.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Biotechnology Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents
• Services
• Software

Global Biotechnology Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Nano Biotechnology
• PCR Technology
• DNA Sequencing
• Chromatography
• Tissue Engineering and Regeneration
• Cell-Based Assays
• Fermentation
• Others

Global Biotechnology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Bio-pharmacy
• Bio-industrial
• Bio-services
• Bioinformatics
• Bio-agriculture

Global Biotechnology Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Academic and Research Institutes
• Others

Global Biotechnology Market Size & CAGR (2025-2032)

• North America (Product Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Product Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Amgen Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech (Roche) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moderna, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vertex Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novozymes (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celgene Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC (UK/Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations